You are here: Industry Insights > blood

News List

Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner PharmaSources
September 18, 2024
Cordlife unveiled its enhanced processing and storage facility, featuring strengthened operational protocols and an advanced laboratory monitoring system, among other improvements.
AHA News: Dangerous Bleeding Strokes Disproportionately Affect Asian American, Pacific Islander Adults drugs.com
February 08, 2022
Asian and Pacific Islander adults in the U.S. are disproportionately affected by a deadly type of stroke that causes bleeding into the brain...
New blood test can identify presence of cancer pharmatimes
January 05, 2022
The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented.
NICE publish final guidance recommending Aspaveli in adults with ultra-rare blood disorder PharmaTimes
December 10, 2021
The drug is additionally undergoing assessment with the Medicines and Healthcare products Regulatory Agency for a marketing authorisation in the UK.
Thrombolytic Science Granted US Patent on Novel Clot Dissolving Therapy, Complementing Patent Protection in Europe, Japan, China, Hong Kong, S.A.R., China, Mexico & CIS B3Cnewswire
October 29, 2021
Thrombolytic Science, LLC (TSI) today announced the granting of a new patent by the USPTO. Most strokes and all heart attacks are caused by a blood clot blocking essential blood flow to a portion of the brain or heart.
Novel blood cleansing device to enter first-in-human trial europeanpharmaceuticalreview
March 22, 2021
The Garnet? therapeutic product, which can capture more than 100 clinically relevant bacteria, fungi, parasites, toxins and viruses from the blood, will soon begin clinical testing.
Speedy Detection of 13 Cancer Types using a Tiny Amount of Blood: microRNA Detection Technology prnasia
January 27, 2021
Globally, about 1 in 6 deaths is due to cancer. With advances in treatment, early detection and treatment of cancer greatly improves survival rates of patients.
Adequate levels of vitamin D reduces complications, death among COVID-19 patients worldpharmanews
September 27, 2020
Hospitalized COVID-19 patients who were vitamin D sufficient, with a blood level of 25-hydroxyvitamin D of at least 30 ng/mL (a measure of vitamin D status), had a significant decreased risk for adverse clinical outcomes including becoming unconscious ...
As Convalescent Plasma is Authorized for Use as a Treatment Against COVID-19 in the US and China, Blood Banks Call for Donations prnewswire
June 23, 2020
ResearchAndMarkets.com has published a new article on the blood banks industry "Blood Banks Call for Donations of Convalescent Plasma to Fight COVID-19".
FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19 americanpharmaceuticalreview
April 09, 2020
The U.S. Food and Drug Administration (FDA) continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19.